Top Pharmaceuticals companies in Australia by Return on Equity (ROE)

This ranking features the top 15 Pharmaceuticals companies in Australia ranked by Return on Equity (ROE), averaging a Return on Equity (ROE) of -15.80%, for January 15, 2025.
#
Name
Return on Equity (ROE)
Reported Date
Stock Price
Change
Price (30 days) Country
1
44.10%
June 30, 2024 USD 157.25 0.24%

Australia

2
17.55%
June 30, 2024 USD 7.32 6.16%

Australia

3
15.24%
June 30, 2024 USD 173.13 0.11%

Australia

4
13.48%
June 30, 2024 USD 2.14 0.82%

Australia

5
11.06%
June 30, 2024 USD 20.43 1.47%

Australia

6
7.29%
June 30, 2024 USD 1.33 6.17%

Australia

7
4.04%
June 30, 2024 USD 21.11 1.40%

Australia

8
3.50%
Dec. 31, 2023 USD 15.47 4.25%

Australia

9
0.52%
Jan. 31, 2024 USD 1.81 -0.44%

Australia

10
-14.57%
Dec. 31, 2023 USD 1.27 -1.68%

Australia

11
-18.31%
June 30, 2024 USD 1.58 -2.06%

Australia

12
-22.54%
June 30, 2024 USD 1.93 -0.52%

Australia

13
-24.63%
June 30, 2024 USD 0.62 -2.68%

Australia

14
-38.36%
June 30, 2024 USD 2.80 2.04%

Australia

15
-235.41%
Dec. 31, 2023 USD 5.88 0.14%

Australia

Frequently Asked Questions
  • Which Pharmaceuticals company in Australia has the highest Return on Equity (ROE) ?

    The Pharmaceuticals company in Australia with the highest Return on Equity (ROE) is Pro Medicus Limited (ASX: PME.AX) at 44.10%.

  • Which Pharmaceuticals company in Australia has the lowest Return on Equity (ROE) ?

    The Pharmaceuticals company in Australia with the lowest Return on Equity (ROE) is Anteris Technologies Ltd (ASX: AVR.AX) at -235.41%.